Olon, a global API provider and contract development and manufacturing organization (CDMO), has confirmed the construction timeline for its advanced facility in Rodano, Milan. Dedicated to ultra-potent compounds, the site will reach full-scale production by January 2025. Currently, the small-scale
Catalyx, a global automation specialist, has announced a strategic partnership with INEL to develop end-to-end packaging solutions for the pharmaceutical and medical device sectors. The collaboration is designed to improve inspection, verification, and compliance standards for high-volume pharmaceutical production. Based
Scorpius Holdings, Inc., an integrated contract development and manufacturing organisation (CDMO), has announced a strategic partnership with Celltheon Corporation to enhance cell line development services for clients. The collaboration leverages Celltheon’s proprietary GOLDILOCKS platform to provide a transposase-based cell line
Vernal Biosciences, a CDMO democratizing the use of mRNA has announced the appointment of Jim Petrilla as its new Chief Executive Officer and Board Director, effective immediately. Petrilla will take over from founding CEO Christian Cobaugh, Ph.D., who will continue
Teijin Limited and Hilleman Laboratories have announced a strategic collaboration to drive growth in contract development and manufacturing organisation (CDMO) services for cell and gene therapies. The partnership, marked by the recent signing of a Memorandum of Understanding (MoU), will
Sterling Pharma Solutions, a global contract development and manufacturing organisation (CDMO), has initiated the second phase of its expansion strategy at its Deeside, UK, facility with an investment exceeding £10 million. The expansion includes a new 2,300-square-foot suite aimed at
Abzena, a contract development and manufacturing organisation (CDMO) specialising in complex biologics and bioconjugates, has announced an expansion of its quality control (QC) testing capacity at its San Diego, California manufacturing site. This new laboratory aims to enhance testing services,
RTI Surgical, a contract development and manufacturing organisation has announced the completion of a new $15 million, 5,000 sq-ft Class III medical device facility in Alachua, Florida, aiming to meet rising demand in the regenerative medicine sector. This facility, which
Resolian, a global bioanalytical contract research organization (CRO), has announced significant leadership changes to support its expansion and operational capabilities. Rob Stachlewitz has been appointed as the new Chief Executive Officer (CEO), effective immediately. He succeeds Pat Bennett, who will
Life Molecular Imaging (LMI), a contract development and manufacturing organization has partnered with PharmaLogic Holdings Corp. to provide and distribute Neuraceq, an FDA-approved imaging agent for Alzheimer’s diagnostics, from PharmaLogic’s manufacturing site in Cincinnati, Ohio. This partnership aims to increase
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
